International Clinics
Daily
FDA approves asundexian, the first factor XIa inhibitor to prevent repeat stroke
On 9 November 2026 the FDA approved Bayer's Sunharbo (asundexian).
On 9 November 2026 the FDA approved Bayer's Sunharbo (asundexian).
Actor Christina Applegate said on her podcast MeSsy that her doctor told her she does not have multiple sclerosis.
Nothing more to show